Adrian Lam

Adrian Lam is an investor-operator with more than 20 years of experience across the healthcare sector, spanning medtech, biotech, and life sciences tools. He combines a decade of experience developing FDA-approved medical devices and leading R&D teams with over 10 years in equity research and portfolio management across private and public healthcare markets. Adrian is the CEO of CorVista Health, an AI-enabled cardiovascular diagnostics company. He also serves as Partner at Bioworld Ventures and Venture Partner at Verge HealthTech Fund and Vectr Ventures. In addition, he contributes to Hong Kong’s innovation ecosystem as a member of the Hong Kong Science and Technology Parks’ Incu-Bio panel, the Hong Kong Government’s Innovation and Technology Fund assessment panel, and the Peer Review Expert Panel for the Raise+ Scheme. Previously, Adrian held roles in venture and business development at Genesis Medtech Group and was a portfolio manager at Sectoral Asset Management, a global healthcare specialist investment firm. Earlier in his career, he led an R&D group at Stryker Corporation. Adrian is a CFA Charterholder.